Driven by advancements in semaglutide formulations and an increased emphasis on medically supervised programs, healthcare providers and patients alike are navigating new standards for safety, access, and long-term metabolic support
Alkems Semasize bioequivalence study, as reported in CDSCO documentation, showed pharmacokinetic ratios within the regulatory acceptance range
At starting doses, this shortfall might delay the onset of noticeable appetite suppression
Caution and Liability For these and other reasons, there is more of a focus on the Liability sector as we head into the second half of the year
Glowy, Dewy, and Soft, Oh My
From celebs like Serena Williams to your best friends sister, everyone seems to know someone whos on one